Olopatadine (Ophthalmic)
Brand Names : Patanol
Before Using This MedicineIn deciding to use a medicine,
the risks of using the medicine must be weighed against the good it will do.
This is a decision you and your doctor will make. For olopatadine, the following
should be considered:
Allergies - Tell your doctor if you have ever had any unusual or
allergic reaction to olopatadine. Also tell your health care professional
if you are allergic to any other substances, such as certain preservatives.
Pregnancy - Olopatadine has not been studied in pregnant women.
However, studies in animals have found that this medicine given in extremely
high doses results in a decreased number of live births; it has not been found
to cause birth defects. Before using this medicine, make sure your doctor
knows if you are pregnant or if you may become pregnant.
Breast-feeding - It is not known whether olopatadine passes into
human breast milk. However, it does pass into the milk of animals with nursing
young. Discuss with your doctor whether or not to breast-feed while using
this medicine.
Children - Studies on this medicine have been done only in adult
patients, and there is no specific information comparing use of olopatadine
in children up to 3 years of age with use in other age groups.
Older adults - Many medicines have not been studied specifically
in older people. Therefore, it may not be known whether they work exactly
the same way they do in younger adults or if they cause different side effects
or problems in older people. There is no specific information comparing use
of olopatadine in the elderly with use in other age groups.
Other medicines - Although certain medicines should not be used
together at all, in other cases two different medicines may be used together
even if an interaction might occur. In these cases, your doctor may want to
change the dose, or other precautions may be necessary. Tell your health care
professional if you are taking or using any other prescription or nonprescription
(over-the-counter [OTC]) medicine.
|